chartexchange

CARM
CARISMA THERAPEUTICS INC
stockOTC

EODOct 2, 2026
0.0005USD0.000%(0.00)1,601
Loading…
Loading…
Healthcare
Biotechnology
HQ
Philadelphia, PA, USA
Previous Close
$0.00
Beta
-74.41
52-Week High
$0.29 2025-10-09
52-Week Low
$0.00 2026-06-08
SMA 50
$0.00
SMA 200
$0.02
Avg. Vol 10D
2,680
Avg. Vol 30D
7,107
Avg. Vol 90D
21,491
Relative Vol
0.23
30.14M
CARM Profile

eleven biotherapeutics is focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics to improve human health and treat disease. eleven biotherapeutics' scientists are engineering protein-based drugs using newly available structural information and the company's unique molecular understanding of clinical effects to create the next generation of protein-based medicines to treat important diseases with unmet needs, such as inflammatory conditions and coagulation disorders.

CARM Performance
PeriodPriceDateChangeBeta
1W0.002026-09-28-28.57%-2.259
1M0.002026-09-04-28.57%4.430
3M0.012026-07-06-91.53%-5.564
6M0.032026-04-06-98.52%-176.631
1Y0.262025-10-06-99.81%-74.407
2Y0.952024-10-04-99.95%—
5Y3.612023-03-09-99.99%-15.640
CARM Stock Summary

CARISMA THERAPEUTICS INC (OTC:CARM) stock price today is $0.00, and today's volume is 1,601. CARM is up 0.000% today. The 30 day average volume is 7,107. CARM market cap is $20,894 with 41.79M shares outstanding.